CA
MRNA icon

CoreCap Advisors’s Moderna MRNA Stock Holding History

CoreCap Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$322K Buy
4,595
+3,931
+592% +$203K 0.01% 691
2026
Q1 		$33.7K Buy
664
+139
+26% +$6.49K ﹤0.01% 1475
2025
Q4 		$15.5K Sell
525
-700
-57% -$19K ﹤0.01% 1788
2025
Q3 		$31.6K Sell
1,225
-10
-0.8% -$279 ﹤0.01% 1496
2025
Q2 		$34.1K Buy
1,235
+121
+11% +$3.19K ﹤0.01% 1405
2025
Q1 		$31.6K Sell
1,114
-4
-0.4% -$142 ﹤0.01% 1362
2024
Q4 		$46.5K Sell
1,118
-98
-8% -$4.68K ﹤0.01% 1210
2024
Q3 		$81.3K Buy
1,216
+28
+2% +$2.57K ﹤0.01% 1003
2024
Q2 		$141K Buy
1,188
+16
+1% +$2.02K 0.01% 429
2024
Q1 		$125K Buy
+1,172
New +$118K 0.01% 769
2022
Q4 		$387K Buy
+2,155
New +$352K 0.03% 399
2022
Q3 		– Sell
-1,797
Closed -$257K – 1482
2022
Q2 		$257K Buy
+1,797
New +$257K 0.02% 453
2022
Q1 		– Sell
-859
Closed -$218K – 1476
2021
Q4 		$218K Buy
+859
New +$251K 0.01% 516

Other funds holding MRNA

DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
RA
REX Advisers Fairfield, Connecticut $37.3M AUM
BG
BDF Gestion Paris, France $747M AUM 47.35% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return
MC
Mirabaud & Cie Geneva, Switzerland $249M AUM 43.75% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return